There are many different Cetyl Myristoleate variants and related products on the market today. And there are several which, either through ignorance or unethical marketing, have contributed to extensive confusion in the nutritional and healthcare industry. There are a couple of issues that need to be clarified.
CMO is a trademarked product that is being sold as cerasomal cis-9 cetyl myristoleate, an analog of Cetyl Myrisotelate. Ther term cerasomal (waxy body?) will NOT be found in your chemistry texts and was constructed by the manufacturer to set this product apart. The term analog is defined as a “similar” molecule. In other words, CMO contains a similar molecule, but it is not cetyl myristoleate. Analysis, performed on several occasions, using Gas Chromatography, Mass Spectrmetry, and Fleme Ionization Detection has revealed very little, if any, Cetyl Myristoleate in this product. Unfortunately, the manufacturer, as of today, has not disclosed exactlywhat his product is.
Another common mix up is that several other manufacturers started with raw materials that contained high levels of myristic acid instead of myristoleic acid. Myristic acid is the saturated analog and when esterified with cetyl aclohol it produces Cetyl Myristate, not Cetyl Myristoleate. Before the sophisticated diagnostic procedures to analyze for CM8 were developed, may of these products were analyzed using improper methods. These products are on our health store shelves and in the network marketing industry being sold as Cetyl Myristoleate, but in fact are Cetyl Myristate.
If you are looking for genuine CM8, buyer beware. Make sure you are getting exactly what you expect. Read the labels look for the term CM8 and understand the differences.
Gas Chromatography – Flame ionization Detection (GC-FID) analysis is now considered the most accurate technique for detecting Cetyl Myristoleate (CM8) levels.